Comparing lymph node removal approaches in aggressive prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial compares two surgical approaches for removing lymph nodes during prostate cancer surgery in men with high-risk disease on one side of the prostate. The goal is to determine whether removing lymph nodes from both sides or just one side provides better outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with prostate cancer that is high-risk (based on grade, size, PSA level, or imaging)
- Your cancer appears to be on one side of the prostate only, confirmed by biopsy and imaging scans
- You have not received any prostate cancer treatment before surgery (no hormone therapy, chemotherapy, or radiation)
- You are fit enough for surgery and expected to live more than 10 years
- You have had a prostate biopsy with at least 10 tissue samples taken
- You have had recent imaging scans (MRI and/or PSMA PET scan) to confirm your cancer stage
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether removing lymph nodes during prostate removal helps predict outcomes in men whose scans do not show spread. It may help improve how doctors decide who benefits from lymph node surgery based on your risk level and scan results.
This trial studies whether operating on a small, one-sided (unilateral) area of prostate cancer spread in the pelvic lymph nodes—found on a PSMA PET scan—can help control recurrence. It’s meant for people whose PSA is still low and whose spread appears limited on the scan.
This trial tests a surgery to remove lymph nodes in the pelvis that still show cancer after your initial prostate cancer treatment. By taking them out, it may help control the cancer and delay the need for stronger treatments.
This study tests two different radiation approaches for men with prostate cancer that has returned after surgery and is found only in the pelvic lymph nodes. The goal is to see if one schedule is better at controlling the disease while limiting side effects.
This trial compares two nerve-sparing surgery techniques for prostate cancer to see which one better protects urinary control and sexual function while still removing the cancer. It may help men with early-stage prostate cancer who are planning to have robotic surgery.
This trial compares radical prostatectomy (surgery to remove the prostate) alone versus surgery plus pelvic lymph node removal, with or without additional radiation, for men with intermediate- or high-risk prostate cancer that has not spread. It aims to see which approach is more effective and safe.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.